✦ LIBER ✦

A case of neurosarcoidosis with necrotizing granuloma expressing angiotensin-converting enzyme

✍ Scribed by Shinji Kitajima; Norihiko Sakai; Kengo Furuichi; Miki Tomokage; Akinori Hara; Kiyoki Kitagawa; Seiko Sawada Kitamura; Yoh Zen; Mitsutoshi Nakada; Shuichi Kaneko; Takashi Wada

Book ID: 106292282
Publisher: Springer
Year: 2010
Tongue: English
Weight: 488 KB
Volume: 20
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-010-0301-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A patient with hepatic granuloma formati

A patient with hepatic granuloma formation and angiotensin-converting enzyme production by granuloma cells during clinical relapse of hepatitis A

✍ Sadataka Inuzuka; Takato Ueno; Hideo Tateishi; Takuji Torimura; Michio Sata; Kyu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 802 KB

A Comparison of Outcomes with Angiotensi

A Comparison of Outcomes with Angiotensin-converting Enzyme

📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 116 KB

A Comparison of Guinea Pig Serum Angiote

A Comparison of Guinea Pig Serum Angiotensin Converting Enzyme with Forms of Angiotensin Converting Enzyme from Human, Rat and Rabbit Tissues

✍ J.W. Ryan; F.A. Valido; A.Y.K. Chung; J.E. Ripka; C.M. Peterson; R.L. Urry 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 344 KB

Angiotensin converting enzyme inhibitor-

Angiotensin converting enzyme inhibitor-induced angioedema: a report of two cases

✍ F. K. Assadi; H. E. Wang; S. Lawless; C. P. McKay; L. Hopp; D. Fattori 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 21 KB

Hypoglycaemia associated with use of inh

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme

✍ R.M.C. Herings; A. de Boer; H.G.M. Leufkens; A. Porsius; B.H.Ch. Stricker 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 516 KB

Metabolic effects of long-term angiotens

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements